艾塞那肽治疗不同体重指数的2型糖尿病患者的效果及安全性分析(3)
 |
| 第1页 |
参见附件。
[4] Defronzo RA，Okerson T，Viswanathan P，et al. Effects of exenatide versus sitagliptin on postprandial glucose，insulin and glucagon secretion，gastric emptying，and caloric intake：a randomized，cross-over study [J]. Curr Med Res Opin，2008，24(10)：2943-2952.
[5] Dushay J，Gao C，Gopalakrishnan GS，et al. Short-term exenatide treatment leads to significant weight loss in a subset of obese women without diabetes [J]. Diabetes Care，2012，35(1)：4-11.
[6] Bunck MC，Cornér A，Eliasson B，et al. One-year treatment with exenatide vs. insulin glargine：effects on postprandial glycemia，lipid profiles，and oxidative stress [J]. Atherosclerosis，2010，212(1)：223-229.
[7] Bello NT，Kemm MH，Ofeldt EM，et al. Dose combinations of exendin-4 and salmon calcitonin produce additive andsynergistic reductions in food intake in nonhuman primates [J]. Am J Physiol Regul Integr Comp Physiol，2010，299(3)：945-952.
[8] Gallwitz B，Guzman J，Dotta F，et al. Exenatide twice daily versus gli mepiride for prevention of glycaemic deterioration in patients with type 2 diabetes with metformin failure (EUREXA)：an open-label，randomised controlled trial [J]. Lancet，2012，379(9833)：2270-2278.
(收稿日期：2013-01-06 本文编辑：张瑜杰)
您现在查看是摘要介绍页，详见PDF附件。